Carregant...
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Lisofylline (LSF), is the R-(−) enantiomer of the metabolite M1 of pentoxifylline, and is currently under development for the treatment of type 1 diabetes. The aim of the study was to develop a physiologically based pharmacokinetic (PBPK) model of LSF in mice and to perform simulations in order to p...
Guardat en:
| Publicat a: | Eur J Drug Metab Pharmacokinet |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954844/ https://ncbi.nlm.nih.gov/pubmed/25663650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-015-0260-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|